# AbCellera

**Canonical:** https://apis.io/providers/abcellera/  
**Website:** https://www.abcellera.com  
**APIs profiled:** 0

AbCellera (NASDAQ: ABCL) is a Vancouver-based antibody discovery and development company that integrates biology, computation, and engineering to develop antibody-based medicines. Its technology platform combines high-throughput single-cell antibody screening, GPCR and ion-channel capabilities, bispecifics, antibody-drug conjugates, structure-based design, and AI for sequence and structure analysis. The company operates a hybrid business model with a co-development partner network (40+ partners and 100+ antibody drug programs since 2015) alongside a growing wholly-owned pipeline that includes ABCL635 (non-hormonal vasomotor symptoms), ABCL575 (atopic dermatitis), ABCL688 (autoimmunity), and ABCL386 (oncology), plus 20+ discovery programs. AbCellera does not publish a public API or developer portal; capabilities are delivered through partner collaborations and contract terms.

## Kin Score — 5.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 5.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 2.6 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Abcellera Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Antibody Discovery, Biotech, Pharmaceuticals, Monoclonal Antibodies, Bispecifics, Antibody-Drug Conjugates, GPCR, Ion Channels, Single Cell, Immunology, Oncology, Celium, Partnerships, Vancouver

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/abcellera/). Scores are computed from the provider's own public artifacts under a published rubric.